Catastrophic metabolic encephalopathies in the newborn period. Evaluation and management

C L Greene1, S I Goodman

  • 1Department of Pediatrics, University of Colorado School of Medicine, Denver, USA.

Clinics in Perinatology
|December 13, 1997
PubMed

Insights

Newborns with neurologic symptoms like seizures may have rare inborn errors of metabolism. Early diagnosis and treatment of these metabolic encephalopathies are crucial to prevent severe outcomes.

Area of Science:

  • Biochemistry
  • Pediatric Neurology
  • Genetics

Background:

  • Inborn errors of metabolism (IEMs) are a significant cause of neurologic symptoms in newborns, including seizures and lethargy.
  • While individually rare, IEMs collectively affect over 1 in 1000 infants, presenting a considerable public health challenge.
  • Symptoms often mimic sepsis or asphyxia, leading to delayed diagnosis and potentially irreversible neurologic damage or death.

Purpose of the Study:

  • To outline key clinical principles for diagnosing metabolic encephalopathies in neonates.
  • To describe the common features of various inborn errors of metabolism presenting in the newborn period.
  • To emphasize the importance of early diagnosis and management for improving outcomes and genetic counseling.

Main Methods:

  • Review of clinical presentations of IEMs in neonates.
  • Application of fundamental clinical principles for diagnosis.
  • Utilization of specific laboratory tests for identification.

Main Results:

  • Most metabolic encephalopathies can be diagnosed using basic clinical approaches and laboratory investigations.
  • Early identification allows for timely intervention, potentially preventing severe morbidity.
  • Diagnosis informs parents about recurrence risks for future children.

Conclusions:

  • Metabolic encephalopathies are an important, treatable cause of neonatal neurologic dysfunction.
  • A systematic approach combining clinical assessment and laboratory testing is effective for diagnosis.
  • Prompt diagnosis and management of IEMs are vital for neonatal neuroprotection and family planning.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...